← Home

About Altitide

Altitide builds and deploys for you so there are no delays and no gaps.

Richard Grewelle

Origins

Altitide was founded to accomplish one goal: help scientists scale nucleotide workflows. Our team's expertise in nucleotide chemistry applied to DNA synthesis, diagnostics, therapeutics, and scientific kit building helps us devise workflows and technologies that are integrated with current demands of our customers. We founded Altitide to work for scientists that need to scale their workflows.

Richard Grewelle, PhD

CEO Altitide
Senior Staff Scientist, Systems Biology Phinomics
Staff Scientist, Systems Biology Phinomics
Senior Scientist, Process Development Elegen Bio
Scientist, Process Development Elegen Bio
Postdoctoral Scholar, Genetics Stanford University
PhD, Biology (Thesis awarded highest prize in mathematical biology) Stanford University
BS, Biology; BS, Mathematics; BS, Chemistry University of Kentucky

Nidhi Gupta, PhD

Strategy Consultant Altitide
Principal Assay Development Scientist Delfi Diagnostics
Staff Scientist and Project Lead Elegen Bio
Senior Manager, NGS Development Freenome
Group Leader, NGS Clinical Takara Bio
Senior Scientist, R&D Shield Diagnostics
Scientist, Product Development Centrillion Technologies
PhD, Genetics and Developmental Biology University of Connecticut

Kubilay Demir, PhD

Scientific Lead Altitide
Principal Scientist Phinomics
Principal Scientist, Preclinical R&D JLI
MLS, Biotech Compliance University of California San Francisco School of Law
Postdoctoral Scholar, HHMI and EMBO Fellow Stanford University
PhD, Cancer Biology and Functional Genomics Heidelberg University

What We Believe

Client Feedback

We listen to your needs and work with you to address your toughest problems with modern solutions.

Quality Over Quantity

Speed is important, but not at the cost of doing it right. Quality at scale is what Altitide does best.

Stay Current

Altitide rides the shifting tide of today's biotech landscape to make sure your tech is state-of-the-art.

Ready to work together?

We'd love to hear about areas of improvement for your nucleotide workflows — let's talk.

Free Consultation